{"id":"https://openalex.org/W2741043391","doi":"https://doi.org/10.1158/1538-7445.am2017-1209","title":"Abstract 1209: FGFR inhibition re-sensitizes BRAF/MEK dual resistant cells to the BRAF/MEK inhibitor combination","display_name":"Abstract 1209: FGFR inhibition re-sensitizes BRAF/MEK dual resistant cells to the BRAF/MEK inhibitor combination","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741043391","doi":"https://doi.org/10.1158/1538-7445.am2017-1209","mag":"2741043391"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-1209","doi":"https://doi.org/10.1158/1538-7445.am2017-1209","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-1209","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062376578","display_name":"Victoria E. H. Wang","orcid":"https://orcid.org/0000-0001-9052-3531","observed_orcids":["https://orcid.org/0000-0001-9052-3531"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria E. Wang","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086227121","display_name":"Jeffrey E. Settleman","orcid":"https://orcid.org/0000-0003-3569-6493","observed_orcids":["https://orcid.org/0000-0003-3569-6493"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Settleman","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088711497","display_name":"Frank McCormic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank McCormic","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"1209","last_page":"1209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr-inhibition","display_name":"FGFR inhibition","score":0.9039999842643738},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cobimetinib","display_name":"cobimetinib","score":1.0},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.6620000004768372},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9179999828338623},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.753000020980835},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7889999747276306},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.753404974937439},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.7124164700508118},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6516828536987305},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6329362392425537},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5767784714698792},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.5142030715942383},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5090179443359375},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4877951443195343},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48607972264289856},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4511980414390564},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34009212255477905},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.321539044380188},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.2689054310321808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23865967988967896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19644927978515625},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.18105056881904602},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.1400420367717743},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-1209","doi":"https://doi.org/10.1158/1538-7445.am2017-1209","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-1209","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1860343172","https://openalex.org/W4393073489","https://openalex.org/W2972384654","https://openalex.org/W3033174922","https://openalex.org/W3106550718","https://openalex.org/W2996253303","https://openalex.org/W1546835108","https://openalex.org/W3217681384","https://openalex.org/W2122841050","https://openalex.org/W2976834141"],"abstract_inverted_index":{"Abstract":[0],"The":[1,131],"BRAF-MEK":[2],"pathway":[3,102],"is":[4,25,92],"frequently":[5],"mutated":[6],"in":[7,19,38,163],"human":[8],"melanoma.":[9],"Inhibitors":[10],"of":[11,36,62,85,90,129,138,143,198],"these":[12,147],"kinases":[13],"have":[14],"proven":[15],"to":[16,29,66,72,122,167,190],"prolong":[17],"survival":[18],"melanoma":[20,39],"patients.":[21],"However,":[22],"clinical":[23],"benefit":[24],"relatively":[26],"short-lived":[27],"due":[28],"acquired":[30],"drug":[31,87,105],"resistance.":[32],"To":[33],"explore":[34],"mechanisms":[35],"resistance":[37,80,166],"cells":[40,76,96,121,134,189],"treated":[41,58],"with":[42,59,165],"dual":[43,132,168,187],"BRAF":[44,54,123,169],"and":[45,64,114,124,170],"MEK":[46,125,171],"inhibitors,":[47],"A375,":[48],"a":[49,68,78,152,156,160],"cell":[50],"line":[51],"harboring":[52],"the":[53,86,95,100,115,120,139,191,199],"V600E":[55],"mutation,":[56],"was":[57,112],"escalating":[60],"doses":[61],"vemurafenib":[63],"cobimetinib":[65],"generate":[67],"cellular":[69],"population":[70],"resistant":[71,133,188],"combination":[73,194],"therapy.":[74],"These":[75,149],"display":[77],"reversible":[79],"phenotype.":[81],"Upon":[82],"initial":[83],"treatment":[84],"combination,":[88],"upregulation":[89],"pSTAT3":[91,101],"observed":[93],"but":[94],"lose":[97],"dependency":[98],"on":[99],"upon":[103],"prolonged":[104],"treatment.":[106],"A":[107],"pharmacological":[108],"synthetic":[109],"lethal":[110],"screen":[111],"performed":[113],"FGFR":[116,161,183],"inhibitor":[117,162,193],"class":[118],"re-sensitizes":[119,185],"inhibition":[126,184],"through":[127],"inhibitions":[128],"pERK.":[130],"also":[135],"displayed":[136],"hyperactivation":[137],"PI3K-AKT":[140],"pathway.":[141],"Interrogation":[142],"patient":[144],"samples":[145],"confirmed":[146],"findings.":[148],"findings":[150],"provides":[151],"biological":[153],"rationale":[154],"for":[155,202],"polytherapy":[157],"strategy":[158],"using":[159],"patients":[164],"inhibition.":[172],"<!\u2013EndFragment\u2013>":[173],"Citation":[174],"Format:":[175],"Victoria":[176],"E.":[177],"Wang,":[178],"Jeffrey":[179],"Settleman,":[180],"Frank":[181],"McCormic.":[182],"BRAF/MEK":[186,192],"[abstract].":[195],"In:":[196],"Proceedings":[197],"American":[200],"Association":[201],"Cancer":[203,216],"Research":[204],"Annual":[205],"Meeting":[206],"2017;":[207],"2017":[208],"Apr":[209],"1-5;":[210],"Washington,":[211],"DC.":[212],"Philadelphia":[213],"(PA):":[214],"AACR;":[215],"Res":[217],"2017;77(13":[218],"Suppl):Abstract":[219],"nr":[220],"1209.":[221],"doi:10.1158/1538-7445.AM2017-1209":[222]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-08-08T00:00:00"}